Mainz BioMed N.V. | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Mainz BioMed N.V.

BRIEF

published on 10/08/2025 at 15:05, 1 month 27 days ago

Mainz Biomed Achieves Promising Results in Pancreatic Cancer Biomarker Study

Early Detection Feasibility Study Mainz Biomed Pancreatic Cancer Biomarker Study
PRESS RELEASE

published on 10/08/2025 at 15:00, 1 month 27 days ago

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
Mainz Biomed reports positive topline results from feasibility study of biomarker panel for pancreatic cancer detection, achieving 100% sensitivity and 95% specificity. The study paves the way for a reliable, non-invasive screening test

Early Detection Feasibility Study Mainz Biomed Pancreatic Cancer Biomarker Panel
BRIEF

published on 09/30/2025 at 14:06, 2 months 4 days ago

Mainz Biomed to Showcase Colorectal Cancer Screening Advances

Mainz Biomed Colorectal Cancer RNA-based Diagnostics WEO Meeting EAArly DETECT Study
PRESS RELEASE

published on 09/30/2025 at 14:01, 2 months 4 days ago

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
Mainz Biomed to present innovative colorectal cancer screening approach at WEO CRC Meeting. Dr. Lena Krammes will discuss RNA-based diagnostics findings for early cancer detection and prevention

Mainz Biomed Colorectal Cancer Screening RNA-based Diagnostics WEO CRC Meeting
BRIEF

published on 09/23/2025 at 14:06, 2 months 11 days ago

Mainz Biomed Launches ColoAlert® Commercially in Switzerland

Mainz Biomed ColoAlert® Cancer Detection Swissmedic Approval Switzerland Launch
PRESS RELEASE

published on 09/23/2025 at 14:01, 2 months 11 days ago

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
Mainz Biomed announces commercial launch of ColoAlert® in Switzerland, marking an important step in providing innovative colorectal cancer screening solutions

Switzerland ColoAlert Mainz Biomed Colorectal Cancer Commercial Launch
BRIEF

published on 09/02/2025 at 14:06, 3 months 2 days ago

Mainz Biomed Registers ColoAlert in the UK

Healthcare Innovation Cancer Screening ColoAlert Mainz Biomed UK Registration
PRESS RELEASE

published on 09/02/2025 at 14:01, 3 months 2 days ago

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
Mainz Biomed announces registration of ColoAlert with UK regulatory agency MHRA, expanding access to DNA-based colorectal cancer screening test

ColoAlert UK Mainz Biomed Colorectal Cancer MHRA
BRIEF

published on 08/13/2025 at 14:06, 3 months 22 days ago

Mainz Biomed Gains Swissmedic Approval for ColoAlert®

Colorectal Cancer Screening Swissmedic Approval ColoAlert® Launch Healthcare Partnerships Diagnostics Innovation
PRESS RELEASE

published on 08/13/2025 at 14:01, 3 months 22 days ago

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
Mainz Biomed receives Swiss regulatory approval to market ColoAlert®, a non-invasive colorectal cancer screening test, following partnership with a local laboratory. The test aims to improve participation rates in CRC screening programs

ColoAlert Mainz Biomed CRC Screening Cancer Detection Swiss Regulatory Approval

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 18 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 23 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 53 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 48 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 53 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 22 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 2 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 27 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 38 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 42 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 53 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 8 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 8 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 52 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE